In vitro fermentation of Bangia fusco-purpurea polysaccharide by human gut microbiota and the protective effects of the resultant products on Caco-2 cells from lipopolysaccharide-induced injury
Mingjing Zheng,Yajun Zheng,Yifei Zhang,Yanbing Zhu,Yuanfan Yang,Tatsuya Oda,Hui Ni,Zedong Jiang
DOI: https://doi.org/10.1016/j.ijbiomac.2022.09.217
IF: 8.2
2022-10-01
International Journal of Biological Macromolecules
Abstract:Polysaccharide extracted from red seaweed Bangia fusco-purpurea (BFP) is a novel sulfated galactan, differed from agarans and carrageenans in fine structure. In this study, in vitro fermentation characteristics of BFP by human gut microbiota and its protective effect on lipopolysaccharide (LPS)-induced injury in Caco-2 cells were investigated. Our results showed that BFP was mainly degraded at transverse colon for 18 h fermentation by gut microbiota with reduced molecular weight. Meanwhile, BFP fermentation was associated with increased short-chain fatty acids (SCFAs) as compared to control group, especially acetic acid was increased to 129.53 ± 0.24 from 82.14 ± 0.23 mmol/L, and butyric acid was up to 1.56 ± 0.004 from 0.62 ± 0.01 mmol/L. Furthermore, BFP promoted abundances of Bacteroidetes and Firmicutes , while decreased numbers of Proteobacteria . The up-regrated beneficial differential metabolites were SCFAs, L-proline, arginine, folic acid, pyridoxamine, thiamine, etc. ( p < 0.05), and their related metabolic pathways mainly included mTOR, arginine biosynthesis, and vitamin metabolism. Notably, BFP fermentation products at transverse colon significantly restored cell viability of LPS-treated Caco-2 cells from 73.79 ± 0.48 % to 93.79–99.64 %, which might be caused by increased beneficial differential metabolites ( e.g. , SCFAs). Our findings suggest that BFP has prebiotic potential and can enhance gut health.
polymer science,biochemistry & molecular biology,chemistry, applied